|
HHV-8, CMV and EBV seropositivity according to age and gender among the 3275 HIV-seronegative healthy blood donors in Ghana |
|||||||||
| Age group, years |
Proportion (%) of HIV-seronegative blood donors with HHV8 seropositivity |
Proportion (%) of HIV-seronegative blood donors with CMV seropositivity |
Proportion (%) of HIV-seronegative blood donors with EBV seropositivity |
||||||
|
|
|||||||||
| Male |
Female |
All |
Male |
Female |
All |
Male |
Female |
All |
|
|
|
|||||||||
| 16–25 |
104/681 (15.3) |
65/335 (19.4) |
169/1016 (16.6) |
558/681 (81.9) |
232/335 (69.3) |
790/1016 (77.8) |
108/681 (15.9) |
74/335 (22.1) |
182/1016 (17.9) |
| 26–35 |
241/1120 (21.5) |
88/220 (40.0) |
329/1340 (24.6) |
831/1120 (74.2) |
158/220 (71.8) |
989/1340 (73.8) |
35/1120 (3.1) |
28/220 (12.7) |
63/1340 (4.7) |
| 36–45 |
118/478 (24.7) |
29/74 (39.2) |
147/552 (26.6) |
423/478 (88.5) |
57/74 (77.0) |
480/552 (87.0) |
223/478 (46.7) |
36/74 (48.6) |
259/552 (46.9) |
| 46–55 |
48/158 (30.4) |
12/42 (28.6) |
60/200 (30.0) |
101/158 (63.9) |
37/42 (88.1) |
138/200 (69.0) |
76/158 (48.1) |
18/42 (42.9) |
94/200 (47.0) |
| 56–65 |
56/136 (41.2) |
16/31 (51.6) |
72/167 (43.1) |
120/136 (88.2) |
25/31 (80.6) |
145/167 (86.8) |
40/136 (29.4) |
18/31 (58.1) |
58/167 (34.7) |
| Total |
567/2573 (22.0) |
210/702 (29.9) |
777/3275 (23.7) |
2033/2573 (79.0) |
509/702 (72.5) |
2542/3275 (77.6) |
482/2573 (18.7) |
174/702 (24.8) |
656/3275 (20.0) |
Adjei et al. BMC Infectious Diseases 2008 8:111 doi:10.1186/1471-2334-8-111 |
|||||||||